Docking of CDK1 with antibiotic drugs revealed novel therapeutic value in breast ductal cancer in situ

Author:

Ding Zhong-Hai1,Qi Jia2,Shang An-Quan34,Zhang Yu-Jie5,Wei Jun5,Hu Li-Qing6,Wang Wei-Wei7,Yang Man8

Affiliation:

1. Department of Senior Cadres’ Healthcare, Jinling Hospital, Medical School of Nanjing University, Nanjing 210002, Jiangsu, China

2. Department of Dermatology, Nanjing Medical University Affiliated Wuxi Second Hospital, Wuxi 214002, Jiangsu, China

3. Department of Laboratory Medicine, Tongji Hospital of Tongji University, Shanghai 200092, Shanghai, China

4. The Sixth People’s Hospital of Yancheng City, Yancheng 224005, Jiangsu, China

5. Clinical Medicine School, Ningxia Medical University, Yinchuan 750004, Ningxia, China

6. Department of Laboratory Medicine, The first Hospital of Ningbo City, Ningbo 315010, Zhejiang, China

7. Department of Pathology, The First People’s Hospital of Yancheng City and The Sixth People’s Hospital of Yancheng City, Yancheng 224001, Jiangsu, China

8. Department of Laboratory Medicine, TCM Hospital of Yancheng City Affiliated to Nanjing University of Chinese Medicine, Yancheng 224001, Jiangsu, China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Search for immunomodulatory compounds with antiproliferative activity against melanoma;Biomedicine & Pharmacotherapy;2023-04

2. CDK1 Dysregulation in Breast Cancer;Therapeutic potential of Cell Cycle Kinases in Breast Cancer;2023

3. CDK Dysregulation in Breast Cancer: A Bioinformatics Analysis;Therapeutic potential of Cell Cycle Kinases in Breast Cancer;2023

4. Expression pattern and prognostic significance of CDKs in breast cancer: An integrated bioinformatic study;Cancer Biomarkers;2022-05-13

5. A Risk Score System Based on the Methylation Levels of 15 RNAs in Breast Cancer;Cancer Biotherapy and Radiopharmaceuticals;2021-02-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3